http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1184567-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a57c8505392f8a03e84e92108c87100a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C255-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-00 |
| filingDate | 1980-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1985-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f21f07c123ddf1e89efdb437ade8e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b3df89ee69003fea4b73fb8f36a4c08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cff4d8dc72734bfd61be8d055fc1689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_daa48c54e66365876e6ef4ba80fb40d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0219f9f5a5649ce339eaae487e69682f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ff299c50c1d49341eb9678214ab4bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0970e2f85832bae023de4b96de99458d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a580cf821113d81988731be49660e4a3 |
| publicationDate | 1985-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1184567-A |
| titleOfInvention | Derivatives of glycinamide, their preparation and their use |
| abstract | ABSTRACT OF THE DISCLOSURE A glycinamide derivative of the general formu]a I : (I) wherein : R is a linear or ramified a]kyl group C5-C18, a linear or ramified alkenyl group C5, C6, C7, C8, C9, C10, C11, C12, C13, C14, C15, C16, C17 or C18, a linear or ramified alkynyl group C4-C10, a linear or ramified acyl group C4-C18, a linear or ramified alkyl group C1-C10, substituted by a phenoxy group, by a hydroxy radical, by an acetoxy radical, by a carboxy radical, by a linear or ramified alkoxycarbonyl group C1-C4, by a carbonyl radical, by a carboxaldehyde group, by an acetal or cetal group, by one or more phenyl groups, by one or more phenyl groups substituted by a halogen atom such as f1uorine, chlorineor bromine, R1 represents hydrogen, a linear or ramified alkyl group C1, C2, C3, C4, C5, C6, C7, C8, C9 or C10, a linear or ramified acyl group C1-C6, a benzoyl group, a linear or ramified alkoxycarbonyl group C1,C2, C3, C4, C5, C6, C7, or C8, a carboxamidomethyl group, R2 represents hydrogen, a linear or ramified alkyl C1, C2, C3, a phenyl group, R3 represents hydrogen, a linear or ramified alkyl group C1, C2, C3, C4, C5, C6, C7 or C8, a phenyl group, optionally substituted by a halogen atom, such as fluorine, chlorine or bromine. R4 represents hydrogen, a linear or ramified alkyl group C1,C2, C3, C4, C5, C6 C7 or C9 as well as salts of these derivatives with non toxic and pharmaceutically usable acids. Such compounds are useful in the treatment of epilepsy and dyskinesiae. |
| priorityDate | 1979-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 226.